News Story: Full Text
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

 

Musella Foundation Awards Grant to Tocagen to Support Clinical Study of Toca 511 & Toca FC in Brain Cancer Patients


Posted on: 07/15/2012

Musella Foundation Awards Grant to Tocagen to Support Clinical Study of
Toca 511 & Toca FC in Brain Cancer Patients
 
HEWLETT, NY, July 16, 2012 – The Musella Foundation For Brain Tumor Research & Information, Inc. (Musella Foundation), a non-profit organization dedicated to improving the lives of families dealing with brain cancer, today announced that it has awarded Tocagen Inc. (www.tocagen.com) a grant to support the clinical investigation of Toca 511 & Toca FC in patients with recurrent Grade 3 glioma brain cancer.  Tocagen is a privately held biopharmaceutical company developing novel treatments for advanced cancer, with an initial focus on brain cancer.
 
This grant supports an important new opportunity for patients with Grade 3 glioma,” said Al Musella, DPM, President of the Musella Foundation.  “It is innovations like Toca 511 & Toca FC that we believe may make a difference in the lives of these patients.”
 
Tocagen is enrolling patients across the U.S. in its investigational clinical trials of Toca 511 (vocimagene amiretrorepvec), for injection & Toca FC (flucytosine), extended-release tablets. These multicenter, open-label studies are evaluating patients with recurrent high-grade glioma, who have had prior surgery and chemoradiation. More details can be found on www.virtualtrials.com  by searching for Tocagen under the “Find a Treatment” tab.
 
“Toca 511 & Toca FC has been designed to kill cancer cells from within while leaving healthy cells unharmed,” said Harry Gruber, M.D., the CEO of Tocagen. “We hope to confirm promising preclinical results for this approach in our ongoing Phase 1/2 studies in patients with Grade 3 glioma and are appreciative to the Musella Foundation for their support of this patient group in our studies.”
 
About the Musella Foundation
The Musella Foundation For Brain Tumor Research & Information, Inc is a 501(c)3 non- profit organization dedicated to speeding up the search for the cure of brain tumors, as well as helping families deal with the diagnosis of brain cancer, by funding innovative brain tumor research, education, advocacy and support for families that are dealing with brain tumors and organizing the brain tumor community to work together as an army to fight the disease. The Musella Foundation is responsible for maintaining the following websites:
www.virtualtrials.com - “Clinical Trials and Noteworthy Treatments For Brain Tumors”
www.braintumorcopays.org  - “Brain Tumor Copayment Assistance Program”
www.walktoendbraintumors.org - “The National Walk To End Brain Tumors”

www.greyribboncrusade.org - “Grey Ribbon Crusade” 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740